1,524 results on '"Warnecke, G."'
Search Results
152. Control of tolerances in turning by predictive control with neural networks
153. Mechanismen der Werkstoffbeanspruchungen sowie deren Beeinflussung bei der Zerspanung mit hohen Geschwindigkeiten
154. Bridge to Thoracic Organ Transplantation in Patients with Pulmonary Arterial Hypertension Using a Pumpless Lung Assist Device
155. Intentional ABO-Incompatible Lung Transplantation
156. Cigarette smoke induced pathophysiological changes in the extracellular matrix but not inflammation as early events in fresh human lung tissue
157. Industrielles Fehlermanagement mit objektorientierten Technologien
158. Aluminum levels and stores in patients with total hip endoprostheses from TiAlV or TiAINb alloys
159. A second order finite difference error indicator for adaptive transonic flow computations
160. A shock indicator for adaptive transonic flow computations
161. Manufacturing of Ceramic Components
162. Industrielles Fehlermanagement mit objektorientierten Technologien
163. Development of a Superabrasive Grinding Wheel With Defined Grain Structure Using Kinematic Simulation
164. Multiple breath washout in pediatric patients after lung transplantation
165. Comparison of IP-10 production induced by ex-vivo stimulation with Respiratory Syncytial Virus (RSV) and the TLR3 agonist Poly I: C in human and non-human primate lung tissues
166. Neue hämodynamische Definition der pulmonalen Hypertonie
167. Rekonstruktion einer komplexen tracheoösophagealen Fistel nach Knopfbatterie-Ingestion bei einem einjährigen Kind unter vv-ECMO Therapie
168. Extrakorporeale Membranoxygenierung als „bridge to transplant“: Veränderung der T-Zellantwort im Langzeitverlauf
169. CMV-Virämien nach Lungentransplantation: Erhöhte Inzidenz für akute Abstoßung und latent veränderte T-Zellantwort im Langzeitverlauf
170. Enhanced Tissue Damage Following H1N1 Infection in Human Precision-Cut Lung Slices (PCLS)
171. Immune Response and Airway Hyperresponsiveness to Respiratory Syncytial Virus Are Impaired in Viable Atopic Lung Tissue Ex Vivo of Non-Asthmatic Donors
172. The Frequency of Tissue-Resident Donor T and NK Cells in Peripheral Blood after Lung Transplantation is Modulated by Normothermic Ex Vivo Lung
173. Perioperative Extracorporeal Membrane Oxygenation-Based Protocol for Massive Acute Pulmonary Embolism
174. Cardiac Transplantation in Higher Risk Patients: Is Ex Vivo Heart Perfusion a Safe Preservation Technique? A Two Center Experience
175. Donor T and NK Cells are Derived from the Donor Lung Parenchyme and Represent Tissue-Resident Memory Cells - An Important Feature for Tolerance Development
176. Cardiac Transplantation across Preformed HLA-Antibody Barriers: Results of a Peritransplant Desensitization Protocol
177. Cytokine Expression and Alloreactivity in a Humanized Mouse Transplant Arteriosclerosis Model Reflects Primary Graft Dysfunction in Lung Transplant Recipients
178. Heart-Associated Cytokine and Endothelial Patterns Dominate the Ischemia Reperfusion Response in Recipients of Combined Heart/Lung Transplantation in Comparison to Lung Transplantation
179. Linking CLAD in Lung Transplant Recipients after 3 Years Follow Up with Transplant Arteriosclerosis in Humanized Mice
180. Correlation between Early B and NK Cell Frequencies and in Relation to CLAD Development and PGD 24h after Lung Transplantation
181. Predicted Total Lung Capacity Ratio between Donors and Recipients Does Not Predict Outcomes in Non-Volume Reduced Lung Transplantation
182. Cytotoxic T Cells Early after Lung Transplantation Precede the Restrictive Allograft Syndrome
183. Alpha1-Antitrypsin Therapy Suppresses Acute Rejection in an Orthotopic Murine Lung Transplantation Model
184. Long (>6h) versus Short (<6h) Clinical Normothermic Ex-Vivo Portable Lung Preservation: Post-Hoc Analysis of OCS Lung EXPAND Trial
185. Five-Year Experience with Treatment of Early Donor Specific Anti-HLA Antibodies in Pediatric Lung Transplant Recipients
186. Five-Year Results of an IgA and IgM-Enriched Human Immunoglobulin G-Based Therapy for Early Anti-HLA Donor Specific Antibodies in 158 Lung-Transplanted Patients
187. Effects of Ex Vivo Perfusion and Il-6 Receptor Blockade on Ischemia Reperfusion Injury in Cardiac Transplantation
188. Lung Transplantation from Donation after Circulatory Death Donors Following Portable Ex-Vivo Lung Perfusion: Post-Hoc Analysis of OCS Lung EXPAND Trial
189. Increased Frequency Of regulatory CD127low T Cells and of IL2+ T Cells Early after Lung Transplant is Associated with Improved Graft Survival
190. Need for and Outcomes of Intraoperative Extracorporeal Circulatory Support in Lung Transplantation for Pulmonary Fibrosis
191. Transplant Arteriosclerosis in Humanized Mice Reflects the Presence of Early Donor-Specific Antibodies in Lung Transplant Recipients and Is Controlled by Autologous Regulatory T Cells
192. Five-Year Results of an IgA- and IgM-Enriched Human Immunoglobulin-Based Therapy for Early anti-HLA Donor-Specific Antibodies after Lung Transplantation
193. Increased Frequency of Regulatory CD127low T Cells Early after Lung Transplant Is Associated with Improved Graft Survival
194. Ex Vivo Heart Perfusion for Higher Risk Cardiac Transplantations: A Retrospective Analysis from Two German Centers
195. Lung Transplant Recipients with Severe Primary Graft Dysfunction Developed Decreased Transplant Arteriosclerosis in Humanized Mice Models
196. ECLS Supported Transport of Intensive Care Unit Patients—Is It Worth the Effort?
197. Finite Volume Evolution Galerkin Methods for Nonlinear Hyperbolic Systems
198. A new Thermo-viscoplastic Material Model for Finite-Element-Analysis of the Chip Formation Process
199. Radiological and Pathological Findings in a Minormismatch Mouse Orthotopic Lung Transplant Model under Immunosuppression.
200. Assessment of long-term cultivated human precision-cut lung slices as an ex vivo system for evaluation of chronic cytotoxicity and functionality
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.